Pancreatic Cancer Research

ResearcherUniversitat de Miguel Hernández d'ElxActive in the last 2 years

Enrique de‐Madaria

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2412-9541; OpenAlex author ID A5011077706, A5059441778. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
34
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: 2 papers · 2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 9

  1. Impact of nutritional status on chemotherapy delivery and outcomes in advanced pancreatic cancer: A prospective multicenter study. Co-author DOI 10.1016/j.clnu.2025.106573↗
  2. CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort. Co-author DOI 10.1007/s11033-020-05245-5↗
  3. Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis. Co-author DOI 10.1177/2050640620938987↗
  4. Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer. Co-author DOI 10.3389/fmed.2020.00495↗
  5. Platelet-to-lymphocyte ratio and CA19-9 are simple and informative prognostic factors in patients with resected pancreatic cancer. Last author DOI 10.1016/j.hbpd.2019.03.011↗
  6. Glycosylation alterations in acute pancreatitis and pancreatic cancer: CA19-9 expression is involved in pathogenesis and maybe targeted by therapy. Last author DOI 10.21037/atm.2019.10.72↗
  7. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain. Co-author DOI 10.1007/s12094-016-1594-x↗
  8. Diagnosis and staging of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12094-017-1681-7↗
  9. Complete pathological response after chemotherapy alone in a patient with pancreatic adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e31824964eb↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vasile Şandru · 3 shared papers, 2020–2026 · strength 0.46
  2. Daniel de la Iglesia · 3 shared papers, 2020–2026 · strength 0.46
  3. Gabriele Capurso · 3 shared papers, 2020–2026 · strength 0.46
  4. Patrick Maisonneuve · 2 shared papers, 2020–2026 · strength 0.34
  5. Mircea Beuran · 2 shared papers, 2019 · strength 0.24
  6. Sorin Hostiuc · 2 shared papers, 2019 · strength 0.24
  7. Ionuţ Negoi · 2 shared papers, 2019 · strength 0.24
  8. Mariia A. Kiriukova · 2 shared papers, 2020 · strength 0.23
  9. Maria A. Kiriukova · 1 shared paper, 2026 · strength 0.23
  10. Marina Macchini · 1 shared paper, 2026 · strength 0.23
  11. Giulia Orsi · 1 shared paper, 2026 · strength 0.23
  12. Lívia Archibugi · 1 shared paper, 2026 · strength 0.23
  13. Paolo Giorgio Arcidiacono · 1 shared paper, 2026 · strength 0.23
  14. Michele Reni · 1 shared paper, 2026 · strength 0.23
  15. Alfredo Carrato · 2 shared papers, 2017 · strength 0.13
  16. Luís Bujanda · 1 shared paper, 2020 · strength 0.09
  17. Marta Herreros‐Villanueva · 1 shared paper, 2020 · strength 0.09
  18. C. Guillén-Ponce · 1 shared paper, 2017 · strength 0.08
  19. Carlos Plaza · 1 shared paper, 2017 · strength 0.04
  20. Antonio Gámez Martínez · 1 shared paper, 2017 · strength 0.04
  21. Alberto Carmona‐Bayonas · 1 shared paper, 2017 · strength 0.04
  22. Rafael Álvarez-Gallego · 1 shared paper, 2017 · strength 0.04
  23. Joaquina Martínez-Galán · 1 shared paper, 2017 · strength 0.04
  24. Mercedes Salgado · 1 shared paper, 2017 · strength 0.04
  25. Berta Laquente · 1 shared paper, 2017 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.